Ehrhardt, M., Craveiro, R. B., Holst, M. I., Pietsch, T., & Dilloo, D. (2014). The PI3K inhibitor GDC-0941 displays promising in vitro and in vivo efficacy for targeted medulloblastoma therapy. Oncotarget.

Ehrhardt, Michael, Rogerio B. Craveiro, Martin I. Holst, Torsten Pietsch, und Dagmar Dilloo. "The PI3K Inhibitor GDC-0941 Displays Promising in Vitro and in Vivo Efficacy for Targeted Medulloblastoma Therapy." Oncotarget 2014.

Ehrhardt, Michael, et al. "The PI3K Inhibitor GDC-0941 Displays Promising in Vitro and in Vivo Efficacy for Targeted Medulloblastoma Therapy." Oncotarget 2014.